Radon exposure is the leading cause of lung cancer among non-smokers in Canada. Raising public awareness is a critical first step toward protecting Canadians from the health risks associated with long-term exposure to high radon levels. Health Canada’s National Radon Program (NRP) was established to characterize the extent of the radon problem in Canada, validate guidance and technologies for radon risk reduction and educate stakeholders
Oncologists worldwide are concerned about the disruptions COVID-19 has caused to cancer treatments. When the world stopped, cancer didn’t. Don’t wait. Get checked!
The federal government has proposed new regulations that threaten your access to life-saving medicines. These changes mean fewer life-changing medicines available to us. It will force Canadians to leave the country for better medical care—if they can afford it. Act now! Visit the website to learn how you can make a difference! New PMPRB Guidelines Effective January 1, 2021 PMPRB Guidelines PMPRB Newsletter: October 2020, Volume 24,
The COVID-19 crisis has heightened anxieties and concerns among patients and caregivers about receiving adequate cancer care. It has also led to postponed appointments, procedures and treatments which have clearly taken a toll on the emotional wellbeing of patients and caregivers. Although interactions with health care professionals continued, they tended to be virtual rather than in-person. However, cancer can’t wait. The delay and cancellation of
The Canadian Cancer Survivor Net would like to congratulate Stewart Campbell, Chairman of ProstAid Calgary for being the recipient of the 2020 Pathfinder Award. The Pathfinder Award is given to individuals who have made a significant contribution to the education, research, treatment, and support for men and their families dealing with prostate cancer. In 2007, Stewart was diagnosed with prostate cancer at the age of
Lynparza is the first targeted treatment approved in biomarker-selected prostate cancer validated by a Phase III trial Read the full press release provided by AstraZeneca Canada Inc.